The two vaccine candidates are vaccines developed by AstraZeneca (AZN.L) and Modern (MRNA.O).
This was stated by WHO Chief Scientist, Soumya Swaminathan, quoted from Reuters, Friday (6/26/2020).
Swaminathan made it possible that the number one of the many vaccine products currently being developed and tested in the world was the vaccine from AstraZeneca.
Get to know AstraZeneca
The British drug company has begun trials of vaccines developed by University of Oxford researchers on humans on a large scale.
AstraZeneca has a Covid-19 vaccine candidate named AZD1222 which was previously named ChAdOx1-S. AstraZeneca’s vaccine candidates have entered the third phase of clinical trials.
“How advanced they can be can be seen from what stage they are at. I think they might be the main candidates. So, maybe they will get fairly early results,” Swaminathan said.
Even in the last week, AstraZeneca has signed an agreement on the tenth supply and production.
The agreement contains an agreement that AstraZeneca will provide 400 million vaccine doses which are currently being developed by the University of Oxford.
AstraZeneca also said they were looking for ways to expand vaccine manufacturing. This British pharmaceutical company claims to be supplying vaccines without profit during the corona pandemic. Deliveries will begin at the end of 2020.
AstraZeneca also promised to supply the vaccine to the government who had struggled to approve the advance purchase of the promising corona immunization treatment.
AstraZeneca has agreed to a global manufacturing agreement to meet the target of producing 2 billion doses of vaccine, including with two businesses supported by Bill Gates and a Rp 17 billion agreement with the US government.
Vaccine from Moderna
While in the second position, according to Swaminathan, the vaccine developed by Moderna is not far from the vaccine from AstraZeneca.
Moderna has another strong candidate for the vaccine, named mRNA-1273.
The vaccine candidate from a company based in Massachusetts, USA, is rumored to be entering a third phase of clinical trials in mid-July.
“We know the Moderna vaccine will also go into phase three clinical trials, maybe starting in mid-July, so the vaccine candidates are not far behind,” he said.
However, he thinks AstraZeneca currently has more global coverage in terms of their vaccine trials.
As is known, currently hundreds of pharmaceutical and biomedical companies are competing to find a vaccine for a new corona virus that has become a pandemic in the world.
There are at least 200 vaccine candidates from different companies that are being developed, 15 of which have entered clinical trials.
At present, WHO is still discussing about developing this potential vaccine with manufacturers from China and researchers from India.
Swaminathan called on developers to consider the Covid-19 vaccine trial collaboration.